AVR-48

N/A

Report date: 2025/05/15 20:00:08
NME

Base Information

Drug NameAVR-48
Drug Alias NameAVR-48
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophages modulatorsToll like receptor 4 modulators
TargetsToll like receptor 4
Therapy Area/IndicationsPseudomonas aeruginosa pneumoniaRespiratory Distress Syndrome, AdultBronchopulmonary Dysplasia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAyuvis Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesAyuvis Research Inc
Inactive CompaniesN/A
Active IndicationsPseudomonas aeruginosa pneumoniaRespiratory Distress Syndrome, AdultBronchopulmonary Dysplasia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A